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In a new drug development, regulatory authorities recommend the ‘‘thorough QT/QTc
study’’, in which the use of a positive control group was recommended for evaluating assay
sensitivity that allows the detection of a QT/QTc interval prolongation about 5msec. The
eﬀects of postural change on the QT/QTc intervals were examined to determine its potential
usefulness as a nonpharmacological positive control. Standard 12-lead electrocardiograms of
72 healthy male subjects (mean age: 22:6 2:0 years) were recorded in the morning and
evening in 6 positions (supine, 30-degree semisitting, standing, supine, 90-degree sitting, and
standing). The QT-RR relationships during postural changes seemed to be similar in the
morning and the evening. The QTc interval calculated by the Fridericia’s or Framingham’s
formula shortened in the sitting (7 to 10msec) and the standing position (11 to 14msec)
compared to that in the supine position. On the other hand, the QTc interval calculated by the
Bazett’s formula prolonged by nearly 4msec in the sitting position and by nearly 9msec in the
standing position. The results suggest that the diﬀerence in QTc interval during postural
change, especially from supine to sitting position, could be useful as a nonpharmacological
positive control.
(J Arrhythmia 2005; 21: 528–535)
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Introduction
QT interval prolongation and associated ventric-
ular arrhythmias, including torsade de pointes (TdP),
are critically important examples of drug-induced
fatal cardiotoxicity.1,2) QT prolongation represents
part of the pharmacological actions of antiarrhyth-
mic drugs which exert them by directly aﬀecting the
process of myocardial repolarization. Other classes
of drugs are expected to exhibit this activity to a
lesser extent. However, drug-induced QT prolonga-
tion and associated proarrhythmias have been major
causes for the withdrawal of non-antiarrhythmic
drugs, which include antiallergic drugs.1,3) There-
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fore, it is essential to evaluate in detail the potential
of a drug to prolong the QT interval at each stage of
a clinical trial.
The ICH (International Conference on Harmoni-
sation of Technical Requirements for Registration of
Pharmaceuticals for Human Use) developed a guide-
line for ‘‘Clinical Evaluation of QT/QTc Interval
Prolongation and Proarrhythmic Potential for Non-
antiarrhythmic Drugs’’.4) This guideline is featured
by its recommendation for a healthy subject to
undergo ‘‘thorough QT/QTc study’’ at a relatively
early stage of clinical trial. This study requires the
evaluation of assay sensitivity which allows the
detection of a QT/QTc interval prolongation by less
than 5msec on average.4) To evaluate assay sensi-
tivity itself, furthermore, the study recommends the
use of a drug—whose average QT interval prolon-
gation is known to last approximately 5msec—as
positive control. In Japan, however, the following
aspects concern the use of positive control: 1) the
occurrence of many drawbacks is foreseen in
acquiring positive control in the case that the drug
is not prepared internally at an institution; and 2)
concern about the safety of positive control which
provokes QT interval prolongation; and 3) ethical
issue of administering such a drug.
Postural changes, e.g., from the supine to sitting or
standing position, are known to aﬀect the QT/QTc
intervals5,6) or QT dispersion.7) We postulated a
hypothesis that the alterations in QT/QTc intervals
which are associated with postural changes can
possibly be used as ‘‘nonpharmacological positive
control’’ to evaluate assay sensitivity as does
pharmacological positive control. In this study, we
examined the relevant alterations to verify our
hypothesis.
Methods
1) Subjects
Seventy-two Japanese healthy male subjects 20 to
30 years of age (mean age: 22:6 2:0 years) were
enrolled in this study. All subjects took no drugs of
any kind for at least one week before this study.
Alcohol was prohibited for at least two days before
this study. All the subjects provided their written
informed consent for enrollment.
2) Postural change procedure and data acquis-
ition
This study was conducted in the evening (between
5 p.m. and 7 p.m.) and in the morning (between
9 a.m. and 11 a.m.). Posture was changed according
to the following sequence: (1) supine position (10
minutes); (2) 30-degree passive semisitting position
(4 minutes); (3) spontaneous standing position (4
minutes); (4) supine position at rest (10 minutes); (5)
90-degree passive sitting position (4 minutes); and
(6) spontaneous standing position (4 minutes). The
subject took the supine/semisitting and sitting
positions on an electrically reclinable bed. The
semisitting position was deﬁned as a position in
Table 1 RR and QT intervals during postural changes in healthy subjects.
RR interval QT
II V5
evening
supine 968:8 140:3 
’%

408:2 27:8 
’%

409:7 27:9 
’%
semisitting 947:3 133:4 404:3 26:5 404:6 26:6
standing 734:4 111:9

360:1 23:7

361:7 25:5

supine 996:0 140:4 
’%

413:8 26:7 
’%

414:7 27:1 
’%
sitting 829:5 119:0 381:2 24:2 380:9 25:0
standing 732:5 116:3

361:5 24:3

363:2 25:9

morning
supine 1101:8 132:0 
’%

431:5 23:4 
’%

433:6 24:9 
’%
semisitting 1063:8 128:7 424:9 23:2 426:1 24:6
standing 810:0 124:3

377:1 25:7

381:4 26:4

supine 1092:5 133:7 
’%

430:6 22:0 
’%

433:8 23:4 
’%
sitting 915:8 124:5 396:7 23:6 398:3 25:2
standing 787:4 121:2

373:4 22:8

377:1 24:3

All values represent mean SD
p < 0:0001
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which the subject inclines his upper body by 30 on
the bed, and the sitting position by 90. Posture was
changed passively on the bed from the supine to
semisitting position and from the semisitting to
sitting position. Furthermore, posture was changed
actively beside the bed from the semisitting to
standing position and from the sitting to standing
position. Alcohol-impregnated cotton was used to
suﬃciently remove sebum at the speciﬁed points
before applying the disposable electrodes for elec-
trocardiography, and posture was then changed.
While maintaining the posture, the standard 12-lead
electrocardiograms (ECGs) were recorded by digital
ECG recorder (Fukuda FCP-5000; Fukuda-Denshi
Co, Tokyo, Japan) for 10 seconds. The ECGs were
stored in a digital format with a sampling frequency
of 500Hz and a bandwidth of 0.25 to 150Hz as a 12-
bit resolution of the 12 simultaneously recorded
leads.
3) QT interval measurement
One cardiologist (Y.K.) measured the QT interval
on all sample ECGs in a semiautomatic manner.
Leads II and V5 were selected for electrocardio-
graphic analysis. An automated measurement soft-
ware programmed for a personal computer (QTD-1;
Fukuda-Denshi Co., Tokyo, Japan) was used to
analyze electrocardiographic records in stock. Sub-
sequently, the cardiologist magniﬁed the ordinate
and abscissa on the display of the personal computer
to measure the QT interval by manually correcting
the start of the Q wave and the end of the T wave.
The end of the T wave was deﬁned to be the point
where T wave returns to the isoelectric line on ECG,
and leads II and V5 were selected as leads to be
measured. The QT interval was measured between
the start of the Q wave and the end of the T wave.
The mean value of all measurable QT intervals (6 to
14 beats per one ECG) was deﬁned as the QT
interval of the ECG. The heart rate-corrected QT
interval (QTc) was calculated using the correction
formulae of Bazett [QTcB ¼ QT/(RR)0:5],8) Frider-
icia [QTcFrid ¼ QT/(RR)0:33],9) and Framingham
[QTcFram ¼ QTþ 0:154ð1 RRÞ].10)
Another cardiologist (S.M.) also measured the QT
interval on the same sample ECGs to assess the
agreement of measurements between the examiners.
4) Statistical analysis
Paired Student’s t-test was conducted to test for
the diﬀerence between two groups. The diﬀerence
among three or more groups was tested by one-way
analysis of variance (ANOVA). Scheﬀe´ test was
conducted for an intergroup diﬀerence when a
signiﬁcant diﬀerence was found by ANOVA. Level
of signiﬁcance was set to <0:05 in all the tests.
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Figure 1 The QT-RR relationships in
healthy subjects in this study.
The QT-RR relationships between the evening
(open circle) and the morning (open triangle)
seem to be similar. The QT-RR interval relation-
ships which were graphed based on QTcs
calculated by the heart rate correction formulae
[Bazett (dotted line), Fridericia (solid line), and
Framingham (dashed line), correspond to the
QTc interval = 414ms] are also shown.
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Table 2 Corrected QT intervals by Bazett, Fridericia and Framingham formulae during postural changes.
QTc (Bazett) QTc (Fridericia) QTc (Framingham)
II V5 II V5 II V5
evening
supine 416:6 18:9 ’%

418:1 17:9 ’%

413:6 17:4 ’%
#
415:0 17:5 ’%
#
413:0 18:2 ’%
#
414:5 17:7 ’%
#semisitting 417:3 18:9 417:6 18:2 412:7 17:1 413:0 17:1 412:4 17:6 412:7 17:3
standing 422:2 16:0 423:8 16:2

400:1 14:8

#
401:7 15:3

#
401:0 13:1

#
402:6 14:3

supine 416:6 18:6 ’%

417:6 17:6 ’%

415:4 16:7 
’%
#
416:4 16:6 
#
’%
#
414:4 17:0 
’%
#
415:4 16:8 
’%
#sitting 420:3 16:3 419:9 15:9 406:6 14:7 406:2 14:6 407:5 13:7 407:2 13:9
standing 424:4 15:9 426:3 14:8

402:0 13:6 403:8 14:3 402:7 12:2 404:4 13:3
morning
supine 412:8 19:2 ’%

414:7 17:8 ’%
#
418:8 17:0 ’%
#
420:7 16:5 ’%
#
415:8 18:1 ’%

417:9 17:4 ’%
semisitting 413:6 19:0 414:7 18:8 417:1 16:5 418:3 17:0 415:0 17:2 416:3 17:7
standing 420:9 15:5

425:6 15:0

#
405:5 13:8

#
410:0 13:8

406:4 12:8

410:6 13:2

supine 413:7 18:8 ’%

416:7 18:9 ’%
#
419:1 15:9 
#
’%
#
422:1 16:6 
#
’%
#
416:3 17:3 
’%
#
419:5 17:9 
’%
#sitting 416:2 15:7 417:8 15:1 409:4 13:7 411:0 14:1 409:6 13:4 411:2 13:7
standing 423:0 17:3 427:1 16:1

405:5 13:1 409:5 13:1 406:2 12:1 409:9 12:3
All values represent mean SD
p < 0:05, #p < 0:001
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Figure 2 Changes in QTc interval from the
supine to other positions.
In the semisitting (sitting in bed with backrest at 30
degrees) position, the QTc interval as calculated by
any heart rate correction formulae showed no statisti-
cally signiﬁcant changes. The QTc interval as
calculated by the Fridericia’s and Framingham’s
correction formula prolonged signiﬁcantly in the
sitting (sitting in bed with backrest at 90 degrees)
and standing position. The QTc interval (Bazett)
showed opposite changes during postural change.
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Results
1) Postural change and the RR and QT intervals
Table 1 shows the alterations in RR and QT
intervals during postural change. Although both the
RR and QT intervals were longer in the morning
than in the evening in any posture, the alterations in
RR or QT interval were similar in intensity in the
morning and the evening. Figure 1 indicates the
relationships between the RR and QT intervals
during postural change. There was an excellent
linear correlation between the mean values of the QT
interval [evening: QT (msec) 414.8–0.202 (1000-RR
(msec)), r ¼ 0:9996, morning: QT ¼ 413:4{0:185
(1000-RR (msec)), r ¼ 0:9999]. The relationships
between the RR and QT intervals were nearly
identical between the morning and the evening.
Furthermore, little diﬀerence was found in the
measured values of the QT/QTc intervals between
leads (II and V5) with respect to any posture
examined.
2) Postural change-induced alterations in cor-
rected QT/QTc intervals
Table 2 and Figure 2 indicate the postural change-
induced alterations in QTc interval which were
corrected by the Bazett’s, Fridericia’s, and Framing-
ham’s formulae. QTcFrid and QTcFram provided
nearly equivalent values in any posture. These two
QTc intervals did not show any signiﬁcant alter-
ations during postural change from the supine to
semi-sitting position and from the sitting to standing
position. During postural change from the supine to
sitting position, QTcFrid and QTcFram shortened by
8.8msec to 11.2msec and by 6.7msec to 8.3msec,
respectively. During postural change from the supine
to standing position, furthermore, QTcFrid and
QTcFram shortened by 10.7msec to 13.5msec and
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Figure 3 Agreement of the measured QT
intervals between two cardiologists.
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by 7.3msec to 12.0msec, respectively. However,
QTcB behaved oppositely during postural change;
namely, QTcB prolonged during postural change
from the supine to sitting or standing position but did
not alter during postural change from the supine to
semi-sitting position or from the sitting to standing
position.
3) Differences in QT interval measurements
between examiners
The diﬀerences in the mean values of the
measured QT intervals between two examiners were
0.3 to 4.6msec in any posture, and the standard
deviations for the diﬀerences were 6.6 to 9.4msec.
Figure 3 shows the alterations in the QTc intervals in
lead II during postural change in the evening. These
changes showed similar patterns, i.e., QTcFrid and
QTcFram shortened signiﬁcantly during postural
change from the sitting to standing position and
from the supine to sitting position, while QTcB
prolonged during postural change from the supine to
standing position. The diﬀerences in the alterations
in the QTc intervals from the supine to sitting
position between examiners were 2.47 to 2.87msec.
However, the inter-examiner QTc diﬀerences from
the supine to standing position exceeded 5msec.
Discussion
Our study revealed that postural changes induced
alterations in the QTc interval by approximately 5 to
10msec. The alterations were not greatly aﬀected at
least by timing for recording (morning and evening)
and the leads with which measurements were
conducted (leads II and V5).
1) Postural changes and QT/QTc intervals
Heart rate increased during postural change from
the supine to sitting or standing position due to the
inhibition of cardiac vagal tone and to an increase in
cardiac sympathetic tone during the change. To
examine alterations in the QT interval during
postural change, therefore, consideration is required
to the direct eﬀects of heart rate and to the eﬀects of
cardiac autonomic tone.
Studies, which investigated the QT-RR interval
relationship by atrial pacing and according to
pharmacological procedures,11,12) reported that the
QT interval was shorter when administering atropine
or atropine plus propranolol than when conducting
atrial pacing and that the QT-RR interval relation-
ship when administering atropin was close to the
relationship observed at the time of exercise stress.
Furthermore, a study which used ambulatory ECG to
compare the QT interval between day and night,13)
disclosed that the Q-T interval is longer during sleep
in the night than during arousal in the day when
compared at the same heart rate.
These ﬁndings suggest that increased cardiac
vagal tone or reduced cardiac sympathetic tone
prolongs the QT interval. Therefore, the eﬀects of
inhibited cardiac vagal tone seem to provide a
greater contribution to alterations in QT interval
because cardiac vagal tone at rest is intense in young
healthy subjects like those in this study.
2) What correction formula is appropriate to
calculate the QTc interval?
This study provided apparently contradictory
alterations, i.e., QTcFrid and QTcFram shortened
during postural change from the supine position to
sitting or standing position, while QTcB prolonged
during the same postural change. As shown in
Figure 1, the Fridericia’s and Framingham’s correc-
tion formulae showed nearly similar correcting
eﬀects on the QT interval at heart rates of 50 to
90 bpm. The slopes of the regression line for QT-RR
intervals during postural change were 0.202 and
0.185 in the evening and morning, respectively;
namely, the values were found between the QT-RR
interval relationships which were graphed, including
QTcs calculated by the Fridericia’s, Framingham’s,
and Bazett’s correction formula. This is considered
to be the reason for the ﬁnding that the QTc interval
exhibited diﬀerent alterations according to the
formulae used. The slopes of the regression line in
this study are close to the mean slope values of the
regression line (0:1713 0:1764, mean SD) as
expressed by the linear model on the QT-RR interval
relationship in the report of Malik et al.14) Therefore,
our results seem to be consistent with the physio-
logical QT-RR interval relationship.
Bazett’s correction formula is one conventional
method of calculating QTc which is still commonly
used. Bazett’s correction formula was proposed, as
were Fridericia’s and Framingham’s formulae, from
the RR-QT interval relationship in a population
study in which ECGs were recorded for individuals
in the supine position. Even when the heart rate of an
individual in the supine position at rest is completely
identical to that of an individual in the standing
position, QT intervals possibly diﬀer if their cardiac
autonomic tone diﬀer. Similarly, the mean values of
the QT-RR interval relationship for individuals in
the supine position at rest and of the QT-RR interval
relationship for individuals during postural change
also possibly diﬀer. Ambulatory ECGs have been
reported to provide relatively constant values within
Kubo Y Postural change-associated alterations in QT/QTc intervals on ECGs
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individuals, although they involve considerable bias
in the RR-QT interval relationship among individ-
uals.14)
As described above, no method is available which
allows the calculation of true QTc simply from heart
rate and QT interval. Therefore, it is impossible to
theoretically demonstrate which correction formula
is optimal. Bazett’s correction formula is known to
make an excessive correction, i.e., QTcB prolongs
when the RR interval is short (at the time of
tachycardia) and shortens at the time of bradycardia
which predisposes TdP. The Fridericia’s correction
formula is highly esteemed in ICH guidelines and
the degree of correction for the heart rate of the
Framingham’s formula has similar to that of the
Fridericia’s formula. In consideration of these facts,
the Fridericia’s or Framingham’s correction formula
seems to be desirable. No matter what formula is
used in the ‘‘thorough QT/QTc study’’, it is
necessary to consider the following possibilities
when a drug in study changes heart rate: QTc may
change in fact due to a drug which does not aﬀect the
process of myocardial repolarization; and, on the
other hand, QTc may remain unchanged even after
administering a drug which aﬀects the process of
myocardial repolarization.
3) QT interval measurement during postural
change as a measure to evaluate assay sensitivity
in the ‘‘thorough QT/QTc study’’
To detect a QT/QTc interval prolongation by less
than 5msec, noise-free excellent ECG records are
required. In this study, therefore, we paid attention to
the pretreatment of the site of electrode application
and used disposable electrodes which allow long-
term application. The standard deviations of QT
interval among individuals were comparable to those
reported by Malik et al.14) Therefore, we consider
that good ECG records were obtained.
This study described postural change from the
supine to sitting position or from the sitting to
standing position as a system which allows the
observation of a QT/QTc alteration by 5 to 10msec.
Postural change from the supine to sitting position,
however, seems more appropriate because of the
smaller inter-examiner diﬀerence in QTc intervals in
this positional change and the diﬃculty in determin-
ing the end of the T wave in the standing position.
Although any of the QT correction formulae seem to
be acceptable to assess assay sensitivity simply, the
Fridericia’s and Framingham’s correction formulae
appear to provide a better impression than the
Bazett’s correction formula with respect to bias in
QTc.
It is necessary to pay attention to some limitations
when using postural change instead of positive
control in the ‘‘thorough QT/QTc study’’. First,
positive control is expected to induce QTc interval
prolongation, while QTc interval shortens due to a
correction formula when using postural change.
Second, positive control allows the evaluation of
assay sensitivity in a double-blind study through the
simultaneous handling of 3 groups, i.e., the placebo,
active drug, and positive control groups, while a
double-blind study is diﬃcult to conduct with
postural change and therefore another independent
study is required apart from an actual clinical trial.
Third, electromyographic noise and ﬂattened T wave
are frequently observed with postural change, espe-
cially in the standing position. Even if the change of
the T wave shape is small, this change may
signiﬁcantly aﬀect the measurement of the QT
interval. Actually, in this study the QTc diﬀerences
between two examiners exceeded 5msec in the
postural change from the supine to standing. On the
other hand, from the supine to sitting position, the
QTc diﬀerences between two examiners were small.
Furthermore, bias in QT/QTc intervals during
postural change was similar to or less than the
standard deviation for the mean value of QT/QTc
interval when administering moxiﬂoxacin.15) There-
fore, our procedure is considered to present an
accuracy which is similar to or better than that of
positive control in evaluating assay sensitivity.
In Japan, the acquisition of positive control is
foreseen to be diﬃcult, and there is an ethical
concern about the use of positive control in a clinical
trial. Furthermore, the possibility that a participant in
a clinical trial refuses the use of positive control is
thought to exist. On the other hand, a comparison of
the QT-RR intervals between preadministration and
the time of maximum blood drug concentration
would possibly allow not only the evaluation of
assay sensitivity but also the observation of the
eﬀects of a drug on the process of myocardial
repolarization if a study by postural change at the
relevant timepoints could be conducted.
In conclusion, postural change, especially from
supine to sitting position, seems to be a useful
method to evaluate assay sensitivity in the ‘‘thorough
QT/QTc test’’.
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